Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Japan
Japan: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 96.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Japan, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Japan stood at 96.0%.
Compared with earlier readings it is up 5.5% on the previous year and unchanged over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Japan peaked at 99.0% in 2016 and was at its lowest, 0.0%, in 2008.
That places Japan 27th out of 194 countries with data for 2025, putting it in the top quarter.
The long-run direction has been consistently rising across the 18 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 88.1% | 0.0% | 99.0% | 10 |
| 2020s | 95.3% | 91.0% | 97.0% | 6 |
Countries ranked near Japan
More health data for Japan
- Heat deaths vs projected death rates 1,294 (2090)
- Un projection of annual infant deaths 178 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 23, male, interpolated 638,500 (2025)
- Age population, age 06, female, interpolated 436,136 (2025)
- Age population, age 25, male, interpolated 633,995 (2025)
- Age population, age 25, female, interpolated 607,213 (2025)
- Age population, age 24, male, interpolated 640,318 (2025)
- Age population, age 24, female, interpolated 611,707 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Japan?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Japan was 96.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Japan?
- The highest recorded value was 99.0% in 2016.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Japan?
- The lowest recorded value was 0.0% in 2008.
- How does Japan rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Japan ranks 27th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Japan?
- Over the last ten years it is unchanged. The long-run trend across the full record is rising.
- Where does this Japan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).